US Stock MarketDetailed Quotes

SIGA SIGA Technologies

Watchlist
  • 6.140
  • +0.090+1.49%
Close Feb 14 16:00 ET
  • 6.140
  • 0.0000.00%
Post 20:01 ET
438.42MMarket Cap5.12P/E (TTM)

About SIGA Technologies Company

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The firm develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY.

Company Profile

SymbolSIGA
Company NameSIGA Technologies
Listing DateSep 9, 1997
Issue Price5.00
Founded1995
CEODr. Diem Nguyen, M.B.A.,PhD
MarketNASDAQ
Employees45
Fiscal Year Ends12-31
Address31 East 62nd Street
CityNew York
ProvinceNew York
CountryUnited States of America
Zip Code10065
Phone1-212-672-9100

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Diem Nguyen, M.B.A.,PhD
  • Chief Executive Officer and Director
  • --
  • Daniel J. Luckshire
  • Executive Vice President, Chief Financial Officer, Corporate Secretary and Principal Accounting Officer
  • 1.72M
  • Dr. Dennis E. Hruby,PhD
  • Executive Vice President and Chief Scientific Officer
  • 1.81M
  • Dr. Holly L. Phillips, M.D.
  • Independent Director
  • 210.33K
  • Evan A. Knisely
  • Independent Director
  • 537.10K
  • Harold E. Ford, Jr
  • Independent Director
  • 200.50K
  • Joseph W. Marshall, III
  • Independent Director
  • 227.07K
  • Jaymie A. Durnan
  • Independent Director
  • 206.58K
  • Julian Nemirovsky
  • Independent Director
  • 218.32K
  • Dr. Gary J. Nabel, M.D.,PhD
  • Independent Director
  • 209.08K
  • Lawrence R. Miller
  • General Counsel
  • --

Trending Stocks

Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve Show More